 | • レポートコード：MRC2304D089 • 出版社/出版日：Transparency Market Research / 2023年1月24日 • レポート形態：英文、PDF、250ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の当調査レポートでは、医療シミュレーションの世界市場を分析し、市場実態を明らかにしています。本書は、エグゼクティブサマリー、市場概要、市場リスク＆動向分析、市場背景、主な成功要因、需要分析＆予測、市場規模分析＆予測、製品＆サービス別（医療シミュレーションソフトウェア、ウェブベースシミュレータ、シミュレーショントレーニングサービス）分析、技術別（仮想患者シミュレーション、3Dプリンティング、処置リハーサル技術）分析、エンドユーザー別（病院、学術機関、軍事機関、研究）分析、地域別（北米、中南米、ヨーロッパ、アジア太平洋、中東・アフリカ）分析、市場構造分析、競争分析などを収録しています。また、CAE (CANADIAN AVIATION ELECTRONICS, LTD.)、LAERDAL MEDICAL、3D SYSTEMS、SIMULAB CORPORATION、SIMULAIDS、LIMBS & THINGS LTD.、KYOTO KAGAKU CO., LTD.、MENTICE AB、GAUMARD SCIENTIFIC COMPANY、SURGICAL SCIENCE SWEDEN ABなどの企業情報を掲載しています。 ・エグゼクティブサマリー ・市場概要 ・市場リスク＆動向分析 ・市場背景 ・主な成功要因 ・需要分析＆予測 ・市場規模分析＆予測 ・世界の医療シミュレーション市場規模：製品＆サービス別 - 医療シミュレーションソフトウェアの市場規模 - ウェブベースシミュレータの市場規模 - シミュレーショントレーニングサービスの市場規模 ・世界の医療シミュレーション市場規模：技術別 - 仮想患者シミュレーション技術の市場規模 - 3Dプリンティング技術の市場規模 - 処置リハーサル技術の市場規模 ・世界の医療シミュレーション市場規模：エンドユーザー別 - 病院における市場規模 - 学術機関における市場規模 - 軍事機関における市場規模 - 研究における市場規模 ・世界の医療シミュレーション市場規模：地域別 - 北米の医療シミュレーション市場規模 - 中南米の医療シミュレーション市場規模 - ヨーロッパの医療シミュレーション市場規模 - アジア太平洋の医療シミュレーション市場規模 - 中東・アフリカの医療シミュレーション市場規模 ・市場構造分析 ・競争分析 |
Medical Simulation Market – Scope of Report
TMR’s report on the global medical simulation market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2033. The report provides revenue of the global medical simulation market for the period 2017–2031, considering 2023 as the base year and 2033 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global medical simulation market from 2023 to 2033.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the medical simulation market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global medical simulation market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global medical simulation market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global medical simulation market.
The report delves into the competitive landscape of the global medical simulation market. Key players operating in the global medical simulation market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global medical simulation market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market medical simulation.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
• Industry Sources:
o WorldWideScience.org
o Elsevier, Inc.
o National Institutes of Health (NIH)
o PubMed
o NCBI
o Department of Health Care Service
• Trade Data Sources
o Trade Map
o UN Comtrade
o Trade Atlas
• Company Information
o OneSource Business Browser
o Hoover’s
o Factiva
o Bloomberg
• Mergers & Acquisitions
o Thomson Mergers & Acquisitions
o MergerStat
o Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
1. Executive Summary
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.1.1. COVID-19 Crisis and Impact on Medical Simulation
3.1.2. COVID-19 Impact Benchmark with Previous Crisis
3.1.3. Impact on Market Value (US$ Mn)
3.1.4. Assessment by Key Countries
3.1.5. Assessment by Key Market Segments
3.1.6. Action Points and Recommendation for Suppliers
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background
4.1. Medical Simulation Market, by Key Countries
4.2. Medical Simulation Market Opportunity Assessment (US$ Mn)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors – Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Growth in Automation, By Country
4.5.3. Patch Management Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Patch Management Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Medical Simulation Market Demand Analysis 2018-2022 and Forecast, 2023-2033
6.1. Historical Market Analysis, 2018-2022
6.2. Current and Future Market Projections, 2023-2033
6.3. Y-o-Y Growth Trend Analysis
7. Global Medical Simulation Market Value Analysis 2018-2022 and Forecast, 2023-2033
7.1. Historical Market Value (US$ Mn) Analysis, 2018-2022
7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Medical Simulation Market Analysis 2018-2022 and Forecast 2023-2033, By Product & Services Type
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) Analysis By Product & Services Type, 2018-2022
8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product & Services Type, 2023-2033
8.3.1. Healthcare Anatomical Models
8.3.1.1. Patient Simulators
8.3.1.2. Task Trainers
8.3.1.3. Interventional/Surgical Simulators
8.3.1.4. Endovascular Simulators
8.3.1.5. Ultrasound Simulators
8.3.1.6. Dental Simulators
8.3.1.7. Eye Simulators
8.3.2. Web-Based Simulators
8.3.3. Healthcare Simulation Software
8.3.4. Simulation Training Services
8.4. Market Attractiveness Analysis By Product & Services Type
9. Global Medical Simulation Market Analysis 2018-2022 and Forecast 2023-2033, By Technology
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) Analysis By Technology, 2018-2022
9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2023-2033
9.3.1. Virtual Patient Simulation
9.3.2. 3D Printing
9.3.3. Procedure Rehearsal Technology
9.4. Market Attractiveness Analysis By Technology
10. Global Medical Simulation Market Analysis 2018-2022 and Forecast 2023-2033, By End-use
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Mn) Analysis By End-use, 2018-2022
10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End-use, 2023-2033
10.3.1. Hospitals
10.3.2. Academic Institutes
10.3.3. Military Organizations
10.3.4. Research
10.4. Market Attractiveness Analysis By End-use
11. Global Medical Simulation Market Analysis 2018-2022 and Forecast 2023-2033, By Region
11.1. Introduction
11.2. Historical Market Size (US$ Mn) Analysis By Region, 2018-2022
11.3. Current Market Size (US$ Mn) & Analysis and Forecast By Region, 2023-2033
11.3.1. North America
11.3.2. Latin America
11.3.3. Europe
11.3.4. Asia Pacific
11.3.5. Middle East and Africa (MEA)
11.4. Market Attractiveness Analysis By Region
12. North America Medical Simulation Market Analysis 2018-2022 and Forecast 2023-2033
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
12.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
12.4.1. By Country
12.4.1.1. U.S.
12.4.1.2. Canada
12.4.1.3. Rest of North America
12.4.2. By Product & Services Type
12.4.3. By End-use
12.4.4. By Technology
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Product & Services Type
12.5.3. By End-use
12.5.4. By Technology
13. Latin America Medical Simulation Market Analysis 2018-2022 and Forecast 2023-2033
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
13.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
13.4.1. By Country
13.4.1.1. Brazil
13.4.1.2. Mexico
13.4.1.3. Rest of Latin America
13.4.2. By Product & Services Type
13.4.3. By End-use
13.4.4. By Technology
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Product & Services Type
13.5.3. By End-use
13.5.4. By Technology
14. Europe Medical Simulation Market Analysis 2018-2022 and Forecast 2023-2033
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
14.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
14.4.1. By Country
14.4.1.1. Germany
14.4.1.2. France
14.4.1.3. U.K.
14.4.1.4. Italy
14.4.1.5. Benelux
14.4.1.6. Nordic Countries
14.4.1.7. Rest of Europe
14.4.2. By Product & Services Type
14.4.3. By End-use
14.4.4. By Technology
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Product & Services Type
14.5.3. By End-use
14.5.4. By Technology
15. Asia Pacific Medical Simulation Market Analysis 2018-2022 and Forecast 2023-2033
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
15.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
15.4.1. By Country
15.4.1.1. China
15.4.1.2. Japan
15.4.1.3. South Korea
15.4.1.4. Rest of Asia Pacific
15.4.2. By Product & Services Type
15.4.3. By End-use
15.4.4. By Technology
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Product & Services Type
15.5.3. By End-use
15.5.4. By Technology
16. Middle East and Africa Medical Simulation Market Analysis 2018-2022 and Forecast 2023-2033
16.1. Introduction
16.2. Pricing Analysis
16.3. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2022
16.4. Market Size (US$ Mn) & Forecast By Market Taxonomy, 2023-2033
16.4.1. By Country
16.4.1.1. GCC Countries
16.4.1.2. South Africa
16.4.1.3. Turkey
16.4.1.4. Rest of Middle East and Africa
16.4.2. By Product & Services Type
16.4.3. By End-use
16.4.4. By Technology
16.5. Market Attractiveness Analysis
16.5.1. By Country
16.5.2. By Product & Services Type
16.5.3. By End-use
16.5.4. By Technology
17. Key Countries Medical Simulation Market Analysis 2018-2022 and Forecast 2023-2033
17.1. Introduction
17.1.1. Market Value Proportion Analysis, By Key Countries
17.1.2. Global Vs. Country Growth Comparison
17.2. US Medical Simulation Market Analysis
17.2.1. Value Proportion Analysis by Market Taxonomy
17.2.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.2.2.1. By Product & Services Type
17.2.2.2. By End-use
17.2.2.3. By Technology
17.3. Canada Medical Simulation Market Analysis
17.3.1. Value Proportion Analysis by Market Taxonomy
17.3.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.3.2.1. By Product & Services Type
17.3.2.2. By End-use
17.3.2.3. By Technology
17.4. Mexico Medical Simulation Market Analysis
17.4.1. Value Proportion Analysis by Market Taxonomy
17.4.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.4.2.1. By Product & Services Type
17.4.2.2. By End-use
17.4.2.3. By Technology
17.5. Brazil Medical Simulation Market Analysis
17.5.1. Value Proportion Analysis by Market Taxonomy
17.5.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.5.2.1. By Product & Services Type
17.5.2.2. By End-use
17.5.2.3. By Technology
17.6. Germany Medical Simulation Market Analysis
17.6.1. Value Proportion Analysis by Market Taxonomy
17.6.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.6.2.1. By Product & Services Type
17.6.2.2. By End-use
17.6.2.3. By Technology
17.7. France Medical Simulation Market Analysis
17.7.1. Value Proportion Analysis by Market Taxonomy
17.7.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.7.2.1. By Product & Services Type
17.7.2.2. By End-use
17.7.2.3. By Technology
17.8. Italy Medical Simulation Market Analysis
17.8.1. Value Proportion Analysis by Market Taxonomy
17.8.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.8.2.1. By Product & Services Type
17.8.2.2. By End-use
17.8.2.3. By Technology
17.9. BENELUX Medical Simulation Market Analysis
17.9.1. Value Proportion Analysis by Market Taxonomy
17.9.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.9.2.1. By Product & Services Type
17.9.2.2. By End-use
17.9.2.3. By Technology
17.10. UK Medical Simulation Market Analysis
17.10.1. Value Proportion Analysis by Market Taxonomy
17.10.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.10.2.1. By Product & Services Type
17.10.2.2. By End-use
17.10.2.3. By Technology
17.11. Nordic Countries Medical Simulation Market Analysis
17.11.1. Value Proportion Analysis by Market Taxonomy
17.11.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.11.2.1. By Product & Services Type
17.11.2.2. By End-use
17.11.2.3. By Technology
17.12. China Medical Simulation Market Analysis
17.12.1. Value Proportion Analysis by Market Taxonomy
17.12.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.12.2.1. By Product & Services Type
17.12.2.2. By End-use
17.12.2.3. By Technology
17.13. Japan Medical Simulation Market Analysis
17.13.1. Value Proportion Analysis by Market Taxonomy
17.13.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.13.2.1. By Product & Services Type
17.13.2.2. By End-use
17.13.2.3. By Technology
17.14. South Korea Medical Simulation Market Analysis
17.14.1. Value Proportion Analysis by Market Taxonomy
17.14.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.14.2.1. By Product & Services Type
17.14.2.2. By End-use
17.14.2.3. By Technology
17.15. GCC Countries Medical Simulation Market Analysis
17.15.1. Value Proportion Analysis by Market Taxonomy
17.15.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.15.2.1. By Product & Services Type
17.15.2.2. By End-use
17.15.2.3. By Technology
17.16. South Africa Medical Simulation Market Analysis
17.16.1. Value Proportion Analysis by Market Taxonomy
17.16.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.16.2.1. By Product & Services Type
17.16.2.2. By End-use
17.16.2.3. By Technology
17.17. Turkey Medical Simulation Market Analysis
17.17.1. Value Proportion Analysis by Market Taxonomy
17.17.2. Value & Analysis and Forecast by Market Taxonomy, 2018-2033
17.17.2.1. By Product & Services Type
17.17.2.2. By End-use
17.17.2.3. By Technology
17.17.3. Competition Landscape and Player Concentration in the Country
18. Market Structure Analysis
18.1. Market Analysis by Tier of Companies
18.2. Market Concentration
18.3. Market Share Analysis of Top Players
18.4. Market Presence Analysis
18.4.1. By Regional footprint of Players
18.4.2. Product footprint by Players
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Benchmarking
19.3. Competition Deep Dive
19.3.1. CAE (CANADIAN AVIATION ELECTRONICS, LTD.)
19.3.1.1. Company Overview
19.3.1.2. Product Portfolio
19.3.1.3. Key Strategies
19.3.2. LAERDAL MEDICAL
19.3.2.1. Company Overview
19.3.2.2. Product Portfolio
19.3.2.3. Key Strategies
19.3.3. 3D SYSTEMS
19.3.3.1. Company Overview
19.3.3.2. Product Portfolio
19.3.3.3. Key Strategies
19.3.4. SIMULAB CORPORATION
19.3.4.1. Company Overview
19.3.4.2. Product Portfolio
19.3.4.3. Key Strategies
19.3.5. SIMULAIDS
19.3.5.1. Company Overview
19.3.5.2. Product Portfolio
19.3.5.3. Key Strategies
19.3.6. LIMBS & THINGS LTD.
19.3.6.1. Company Overview
19.3.6.2. Product Portfolio
19.3.6.3. Key Strategies
19.3.7. KYOTO KAGAKU CO., LTD.
19.3.7.1. Company Overview
19.3.7.2. Product Portfolio
19.3.7.3. Key Strategies
19.3.8. MENTICE AB
19.3.8.1. Company Overview
19.3.8.2. Product Portfolio
19.3.8.3. Key Strategies
19.3.9. GAUMARD SCIENTIFIC COMPANY
19.3.9.1. Company Overview
19.3.9.2. Product Portfolio
19.3.9.3. Key Strategies
19.3.10. SURGICAL SCIENCE SWEDEN AB
19.3.10.1. Company Overview
19.3.10.2. Product Portfolio
19.3.10.3. Key Strategies
20. Assumptions and Acronyms Used
21. Research Methodology